PL4043014T3 - Kompozycja farmaceutyczna zawierająca pochodną heterocyklidenoacetamidu do zastosowania w leczeniu zespołu suchego oka - Google Patents
Kompozycja farmaceutyczna zawierająca pochodną heterocyklidenoacetamidu do zastosowania w leczeniu zespołu suchego okaInfo
- Publication number
- PL4043014T3 PL4043014T3 PL20872061.5T PL20872061T PL4043014T3 PL 4043014 T3 PL4043014 T3 PL 4043014T3 PL 20872061 T PL20872061 T PL 20872061T PL 4043014 T3 PL4043014 T3 PL 4043014T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical composition
- composition containing
- dry eye
- treating dry
- acetamide derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019184053 | 2019-10-04 | ||
| PCT/JP2020/037548 WO2021066144A1 (ja) | 2019-10-04 | 2020-10-02 | ヘテロシクリデンアセトアミド誘導体含有医薬 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4043014T3 true PL4043014T3 (pl) | 2025-08-11 |
Family
ID=75338162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20872061.5T PL4043014T3 (pl) | 2019-10-04 | 2020-10-02 | Kompozycja farmaceutyczna zawierająca pochodną heterocyklidenoacetamidu do zastosowania w leczeniu zespołu suchego oka |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20220370404A1 (enExample) |
| EP (2) | EP4043014B1 (enExample) |
| JP (3) | JP7025094B2 (enExample) |
| KR (1) | KR20220078604A (enExample) |
| CN (1) | CN114585357A (enExample) |
| AU (1) | AU2020361093A1 (enExample) |
| BR (1) | BR112022005992A2 (enExample) |
| CA (1) | CA3156484A1 (enExample) |
| DK (1) | DK4043014T3 (enExample) |
| ES (1) | ES3031607T3 (enExample) |
| HU (1) | HUE072085T2 (enExample) |
| MX (2) | MX2022004027A (enExample) |
| MY (1) | MY207759A (enExample) |
| PH (1) | PH12022550805A1 (enExample) |
| PL (1) | PL4043014T3 (enExample) |
| PT (1) | PT4043014T (enExample) |
| WO (1) | WO2021066144A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK4043014T3 (da) * | 2019-10-04 | 2025-06-23 | Senju Pharma Co | Farmaceutisk sammensætning indeholdende heterocyklidenacetamid-derivat til brug til behandling af tørre øjne |
| JP7175431B1 (ja) * | 2021-03-30 | 2022-11-18 | 千寿製薬株式会社 | ヘテロシクリデンアセトアミド誘導体含有懸濁液 |
| KR20250065723A (ko) | 2022-09-29 | 2025-05-13 | 센주 세이야꾸 가부시키가이샤 | 멸균 처리한 헤테로시클리덴아세트아미드 유도체 함유 현탁액 |
| AU2023352013A1 (en) | 2022-09-29 | 2025-04-03 | Mochida Pharmaceutical Co., Ltd. | Combination preparation containing heterocyclidene acetamide derivative |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5621566A (en) | 1979-08-01 | 1981-02-28 | Alpha- Shokuhin Kk | Preparation of bifun from homegrown rice and apparatus used for it |
| CA2616079C (en) | 2005-07-22 | 2012-09-25 | Mochida Pharmaceutical Co., Ltd. | Novel heterocyclidene acetamide derivative |
| ZA200800959B (en) * | 2005-07-22 | 2009-10-28 | Mochida Pharmaceutical Company | Novel heterocyclidene acetamide derivative |
| TW200927192A (en) * | 2007-11-19 | 2009-07-01 | Alcon Res Ltd | Use of TRPV1 receptor antagonists for treating dry eye and ocular pain |
| US20100210682A1 (en) * | 2009-02-19 | 2010-08-19 | Abbott Laboratories | Repeated Dosing of TRPV1 Antagonists |
| EP2377850A1 (en) * | 2010-03-30 | 2011-10-19 | Pharmeste S.r.l. | TRPV1 vanilloid receptor antagonists with a bicyclic portion |
| WO2012045729A1 (en) * | 2010-10-05 | 2012-04-12 | Glaxo Group Limited | Imidazo [1, 2 -a] pyridine and pyrazolo [1, 5 -a] pyridine derivatives as trpv1 antagonists |
| GB201215857D0 (en) * | 2012-09-05 | 2012-10-24 | Sylentis Sau | siRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions |
| JP6230743B1 (ja) * | 2017-05-31 | 2017-11-15 | 持田製薬株式会社 | ヘテロシクリデンアセトアミド誘導体の結晶 |
| JP7373909B2 (ja) | 2018-04-06 | 2023-11-06 | 株式会社シマノ | 変速制御装置および変速システム |
| DK4043014T3 (da) * | 2019-10-04 | 2025-06-23 | Senju Pharma Co | Farmaceutisk sammensætning indeholdende heterocyklidenacetamid-derivat til brug til behandling af tørre øjne |
-
2020
- 2020-10-02 DK DK20872061.5T patent/DK4043014T3/da active
- 2020-10-02 MY MYPI2022001736A patent/MY207759A/en unknown
- 2020-10-02 US US17/766,090 patent/US20220370404A1/en active Pending
- 2020-10-02 CN CN202080069192.5A patent/CN114585357A/zh active Pending
- 2020-10-02 JP JP2021541679A patent/JP7025094B2/ja active Active
- 2020-10-02 WO PCT/JP2020/037548 patent/WO2021066144A1/ja not_active Ceased
- 2020-10-02 ES ES20872061T patent/ES3031607T3/es active Active
- 2020-10-02 BR BR112022005992A patent/BR112022005992A2/pt unknown
- 2020-10-02 AU AU2020361093A patent/AU2020361093A1/en active Pending
- 2020-10-02 KR KR1020227012080A patent/KR20220078604A/ko active Pending
- 2020-10-02 PT PT208720615T patent/PT4043014T/pt unknown
- 2020-10-02 CA CA3156484A patent/CA3156484A1/en active Pending
- 2020-10-02 HU HUE20872061A patent/HUE072085T2/hu unknown
- 2020-10-02 EP EP20872061.5A patent/EP4043014B1/en active Active
- 2020-10-02 PH PH1/2022/550805A patent/PH12022550805A1/en unknown
- 2020-10-02 MX MX2022004027A patent/MX2022004027A/es unknown
- 2020-10-02 PL PL20872061.5T patent/PL4043014T3/pl unknown
- 2020-10-02 EP EP25164201.3A patent/EP4545095A3/en active Pending
-
2022
- 2022-02-07 JP JP2022017196A patent/JP7248836B2/ja active Active
- 2022-04-01 MX MX2025005474A patent/MX2025005474A/es unknown
- 2022-10-26 JP JP2022171542A patent/JP2023011735A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DK4043014T3 (da) | 2025-06-23 |
| EP4545095A3 (en) | 2025-07-02 |
| WO2021066144A1 (ja) | 2021-04-08 |
| MX2025005474A (es) | 2025-06-02 |
| CA3156484A1 (en) | 2021-04-08 |
| JP7025094B2 (ja) | 2022-02-24 |
| US20250134854A1 (en) | 2025-05-01 |
| CN114585357A (zh) | 2022-06-03 |
| EP4545095A2 (en) | 2025-04-30 |
| MY207759A (en) | 2025-03-17 |
| US20220370404A1 (en) | 2022-11-24 |
| ES3031607T3 (en) | 2025-07-09 |
| HUE072085T2 (hu) | 2025-10-28 |
| JP7248836B2 (ja) | 2023-03-29 |
| JP2022065024A (ja) | 2022-04-26 |
| AU2020361093A1 (en) | 2022-05-19 |
| JP2023011735A (ja) | 2023-01-24 |
| MX2022004027A (es) | 2022-07-19 |
| EP4043014A4 (en) | 2023-10-11 |
| EP4043014B1 (en) | 2025-03-19 |
| PT4043014T (pt) | 2025-06-09 |
| PH12022550805A1 (en) | 2023-10-02 |
| BR112022005992A2 (pt) | 2022-06-21 |
| JPWO2021066144A1 (ja) | 2021-12-02 |
| KR20220078604A (ko) | 2022-06-10 |
| EP4043014A1 (en) | 2022-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE072085T2 (hu) | Gyógyszerészeti készítmény, mely heterocikliden-acetamid-származékot tartalmaz és amely a száraz szem kezelésére szolgál | |
| IL275982A (en) | Pharmaceutical compositions for the treatment of cystic fibrosis | |
| IL290996A (en) | Neurotoxin preparations for headache treatment | |
| IL256085B (en) | A converted derivative of huanic acid, a pharmaceutical preparation containing it and the converted derivative for use in treatment | |
| PT3399962T (pt) | Composição oftálmica para o tratamento da doença do olho seco | |
| EP3261620A4 (en) | Methods and compositions for treating dry eye disease and other eye disorders | |
| IL267159B (en) | A pharmaceutical preparation containing e7386 given in combination with lanuatinib for the treatment of tumors | |
| IL256684B (en) | Medicinal compounds and preparations for the treatment of social disorders and substance use disorders | |
| SI3288588T1 (sl) | Izboljšana sredstva za prečno povezovanje kolagenskih vlaken za uporabo pri zdravljenju kornealne ektazije | |
| SG11202000866TA (en) | Treatment agent composition for textile products | |
| PT3302454T (pt) | Composições para utilização no tratamento da doença de parkinson e distúrbios associados | |
| EP3246037A4 (en) | Crosslinked chondroitin sulfate, composition containing same, and treatment agent for eye disease | |
| IL271758A (en) | Statin preparations and methods for use in the treatment of synuclein pathologies | |
| IL289371A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| PT3215143T (pt) | Combinação compreendendo espirulina e palmitoíletanolamida | |
| PL3406258T3 (pl) | Lek do stosowania w leczeniu dny moczanowej | |
| ZA201807136B (en) | Compositions for use in treating tendon degeneration | |
| HUE047396T2 (hu) | Nem illékony szemészeti készímény, különösen száraz szem szindróma kezelésére | |
| IL280389A (en) | Bile acid receptor modulators conjugated to G.1 protein and methods of using them | |
| PL3229780T3 (pl) | Kompozycje okulistyczne do zastosowania w leczeniu zespołu suchego oka | |
| IL277637A (en) | Sustained release formulation of an eye drug and uses for the treatment of dry eye syndrome | |
| GB2569682B (en) | Topical composition for use in the treatment of burns | |
| ZA201906465B (en) | Compositions and methods for treating dry eye diseases | |
| GB201918539D0 (en) | Compounds for use in treatment and prophylaxis | |
| HK40005766A (en) | Topical composition for use in the treatment of burns |